Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection

Introduction: Lung cancer is one of the most diagnosed malignancies with increasing incidence worldwide. Immunotherapy is the main oncological treatment for advanced non-small cell lung cancer (NSCLC), for which the discovery of new efficient biomarkers is crucial. Scientific evidence points to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Krpina, Kristina, Mavrinac, Martina, Samarzija, Miroslav, Tolic, Ena, Darapi, Dora, Baticic, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695563/
https://www.ncbi.nlm.nih.gov/pubmed/36431171
http://dx.doi.org/10.3390/jcm11226695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695563/
https://www.ncbi.nlm.nih.gov/pubmed/36431171
http://dx.doi.org/10.3390/jcm11226695

Ejemplares similares